EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study

Yi-Chun Chung, Jiann-Horng Yeh, Hou-Chang Chiu, Li-Ming Lien, Wen-Hung Chen

Acta Neurologica Taiwanica · 2025

DOI: 10.4103/ant.ant_112_0081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurologica Taiwanica, 2025. Verfasst von Yi-Chun Chung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, New Taipei City Hospital, New Taipei, Taiwan. Hauptthemen laut MEDLINE: Myasthenia Gravis, Receptor Protein-Tyrosine Kinases, Receptors, Cholinergic, Autoantibodies. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myasthenia gravis (MG) patients with anti-MuSK (muscle-specific tyrosine kinase) antibody (MuSK-MG) are uncommon. Compare with MG patient with anti-ACh (acetylcholine) receptor antibody (AChR-MG), MuSK-MG exhibit unique features.

Objectives

The aim of this study is to analyze the difference of the clinical characteristics and electrophysiological features between MuSK-MG and AChR-MG. Materials and Methods: We retrospectively review the medical records of generalized MG patients from 2004 to 2019 at Shin Kong Memorial Wu Ho-Su Hospital. We enrolled 47 MuSK-MG patients (33 females and 14 males), and 48 AChR-MG patient (23 females and 25 males).

Results

MuSK-MG patients have a female predominance (70.2% vs. 47.9%, P = 0.027) and no significant difference to AChR-MG in onset age (44.02 ± 15.06 vs. 47.52 ± 15.85, P = 0.273). MuSK-MG are more likely to involve facial (76.6% vs. 16.7%, P < 0.001), bulbar (100% vs. 50%, P < 0.001), neck (55.3% vs. 22.9%, P = 0.001), and respiratory muscles (61.7% vs. 10.4%, P < 0.001). MuSK-MG tent to experience more severe symptoms with MGFA Class III or greater (72.3% vs. 50.0%, P = 0.032). The thymic pathology in MuSK-MG is likely to be normal (55.3% vs. 18.8%) or thymic hyperplasia (44.7% vs. 25%). The overall positive rate for repetitive nerve stimulation (RNS) in MuSK-MG patients is less than AChR-MG patients (66.0% vs. 85.4%, P = 0.027). Further analysis shows the difference is mainly by recording from trapezius muscles (51.1% vs. 79.2%, P = 0.004), whereas there is no difference in nasalis muscles (60% vs. 67.6%, P = 0.544) and abductor digiti minimi muscles (13% vs. 18.4%, P = 0.582). The positive rate for single fiber electromyography (SFEMG) recording from orbicularis oculi is very high in both MuSK-MG and AChR-MG (100% vs. 97.2%, P = 0.289). Both MuSK-MG and AChR-MG patients achieved good outcome after proper treatment (68.1% vs. 75%, P = 0.4455).

Conclusions

MuSK-MG patients have a female predominance and more facial, bulbar, neck, and respiratory muscles involvements. The electrodiagnostic features of MuSK-MG are lower positive rate of RNS at trapezius and high positive rate of SFEMG at facial muscles. Although MuSK-MG patients are associated with a more progressive course, proper diagnosis and treatment still can lead to a favorable outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisReceptor Protein-Tyrosine KinasesReceptors, CholinergicAutoantibodiesHumansFemaleMaleRetrospective StudiesAdultMiddle AgedAged

Stichwörter der Autor:innen

Anti-Acetylcholine receptor antibodyAntimuscle-specific tyrosine kinase antibodymyasthenia gravisoutcomerepetitive nerve stimulationsingle-fiber electromyography

Substanzen

Receptor Protein-Tyrosine KinasesReceptors, CholinergicAutoantibodiesMUSK protein, human

Autor:innen und Institutionen

  • Department of Neurology, New Taipei City Hospital, New Taipei, Taiwan.
  • Department of Neurology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
  • Department of Neurology, College of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan.
  • Department of Neurology, Taipei Medical University - Shuang Ho Hospital, New Taipei, Taiwan.
  • Department of Neurology, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Zitieren

APA

Chung, Y. C., Yeh, J. H., Chiu, H. C., Lien, L. M., & Chen, W. H. (2025). Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study. Acta Neurologica Taiwanica. https://doi.org/10.4103/ant.ant_112_0081

Vancouver

Chung YC, Yeh JH, Chiu HC, Lien LM, Chen WH. Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study. Acta Neurologica Taiwanica. 2025. doi:10.4103/ant.ant_112_0081

BibTeX
@article{Chung2025,
  author = {Chung, Yi-Chun and Yeh, Jiann-Horng and Chiu, Hou-Chang and Lien, Li-Ming and Chen, Wen-Hung},
  title = {Clinical Features and Outcome in Myasthenia Gravis Patients with Antimuscle-specific Tyrosine Kinase Antibody: A Retrospective Study},
  journal = {Acta Neurologica Taiwanica},
  year = {2025},
  doi = {10.4103/ant.ant_112_0081}
}
Kostenlos starten →